TOPLINE Menopausal hormone therapy (MHT) initiation in perimenopausal and recently postmenopausal women with vasomotor symptoms was associated with a reduction in the risk for cardiovascular disease (CVD). METHODOLOGY Researchers emulated a sequence of target trials — using data from a longitudinal study of the menopause transition, …
Read More

